ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,92
-0,31%
S&P 500
5.308,13
0,09%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
71.324,79
-0,17%
Brent Oil
83,035
-0,59%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Kiniksa Pharmaceuticals Ltd (KNSA)

  7. Kiniksa Pharmaceuticals Ltd (KNSA) Notícias

KNSA

Kiniksa Pharmaceuticals (KNSA)

Kiniksa Pharmaceuticals Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:KNSA
DataHoraFonteTítuloCódigoCompanhia
07/05/202417:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
23/04/202408:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
16/04/202417:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/04/202408:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Announces Development Indication for AbiprubartNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
05/03/202418:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
01/03/202419:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
28/02/202409:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
28/02/202409:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
21/02/202418:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
14/02/202418:39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
04/01/202409:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Provides Corporate UpdateNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/01/202418:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/11/202317:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
31/10/202308:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
24/10/202317:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
10/08/202317:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
25/07/202308:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
17/07/202309:00GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
08/06/202318:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
07/06/202318:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
06/06/202317:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare ConferenceNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
04/05/202317:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/05/202308:30GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
01/05/202317:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
08/03/202316:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
02/03/202318:26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
28/02/202310:00GlobeNewswire Inc.Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Portfolio ExecutionNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
27/02/202318:01GlobeNewswire Inc.Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on February 28, 2023NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
03/02/202313:52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KNSAKiniksa Pharmaceuticals Ltd
09/01/202310:00GlobeNewswire Inc.Kiniksa Pharmaceuticals Provides Corporate and Portfolio UpdateNASDAQ:KNSAKiniksa Pharmaceuticals Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:KNSA

Seu Histórico Recente

LSE
0OMT
St St Constantine And He...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados